Intestinal and hepatic drug transporters: pharmacokinetic, pathophysiological, and pharmacogenetic roles

被引:0
|
作者
Tomohiro Terada
Daiki Hira
机构
[1] Shiga University of Medical Science Hospital,Department of Pharmacy
来源
关键词
Drug transporters; Pharmacokinetics; Polymorphisms; Drug–drug interaction;
D O I
暂无
中图分类号
学科分类号
摘要
The efficacy and safety of pharmacotherapies are determined by the complex processes involved in the interactions between drugs with the human body, including pharmacokinetic aspects. Among pharmacokinetic factors, it has been recognized that drug transporters play critical roles for absorption, distribution and excretion of drugs, regulating the membrane transport of drugs. The vast amounts of information on drug transporters collected in the past 20 years have been organized according to biochemical, molecular, genetic, and clinical analyses. Novel technologies, public databases, and regulatory guidelines have advanced the use of such information in drug development and clinical practice. In this review, we selected some clinically important drug transporters expressed in the intestine and liver, and introduced the research history and current knowledge of their pharmacokinetic, pathophysiological, and pharmacogenetic implications.
引用
收藏
页码:508 / 519
页数:11
相关论文
共 50 条
  • [31] ASSESSING THE ROLE OF HEPATIC TRANSPORTERS IN DRUG DISPOSITION
    Han, Yong-Hae
    Schilke, Jessica
    Chen, Cliff
    Luo, Gang
    Chong, Saeho
    Yang, Zheng
    Marathe, Punit
    Rodrigues, David
    DRUG METABOLISM REVIEWS, 2008, 40 : 207 - 207
  • [32] Liver Transporters in Hepatic Drug Disposition: An Update
    Li, Peng
    Wang, Guang-Ji
    Robertson, Thomas A.
    Roberts, Michael S.
    CURRENT DRUG METABOLISM, 2009, 10 (05) : 482 - 498
  • [33] Hepatic drug transporters: the journey so far
    Riley, R. J.
    Foley, S. A.
    Barton, P.
    Soars, M. G.
    Williamson, B.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (02) : 201 - 216
  • [34] Intestinal drug transporters in pathological states: an overview
    Marek Drozdzik
    Izabela Czekawy
    Stefan Oswald
    Agnieszka Drozdzik
    Pharmacological Reports, 2020, 72 : 1173 - 1194
  • [35] Intestinal drug transporters in pathological states: an overview
    Drozdzik, Marek
    Czekawy, Izabela
    Oswald, Stefan
    Drozdzik, Agnieszka
    PHARMACOLOGICAL REPORTS, 2020, 72 (05) : 1173 - 1194
  • [36] Effects of Acanthopanax senticosus harms on the activities of intestinal drug transporters and hepatic cytochrome p450
    Tsugita, Keisuke
    Takahashi, Tsunehisa
    Sato, Takashi
    Watanabe, Kazuhiro
    Sato, Juichi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 : 141 - 142
  • [37] Interaction of the antiviral drug telaprevir with renal and hepatic drug transporters
    Kunze, Annett
    Huwyler, Joerg
    Camenisch, Gian
    Gutmann, Heike
    BIOCHEMICAL PHARMACOLOGY, 2012, 84 (08) : 1096 - 1102
  • [38] CIRCADIAN EXPRESSION OF HEPATIC DRUG TRANSPORTERS AND THEIR ROLE IN THE HEPATIC EXCRETION OF PHENOLSULFONPHTHALEIN
    Oh, Ju-Hee
    Kim, Miri
    Lee, Joo Hyun
    Cho, Sehyung
    Han, Dong-Hee
    Lee, Young-Joo
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S94 - S95
  • [39] Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy
    Ieiri, Ichiro
    Takane, Hiroshi
    Hirota, Takeshi
    Otsubo, Kenji
    Higuchi, Shun
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (05) : 651 - 674
  • [40] Roles of Drug Transporters in Blood-Retinal Barrier
    Liu, Li
    Liu, Xiaodong
    DRUG TRANSPORTERS IN DRUG DISPOSITION, EFFECTS AND TOXICITY, 2019, 1141 : 467 - 504